Company Filing History:
Years Active: 2000-2005
Title: Innovations by Jeffrey S. Callahan
Introduction
Jeffrey S. Callahan is an accomplished inventor based in Antioch, TN (US). He has made significant contributions to the field of ophthalmology with his innovative designs for intraocular corrective lenses. With a total of 3 patents to his name, Callahan's work focuses on improving vision correction methods.
Latest Patents
One of his latest patents is for a deformable intraocular corrective lens. This artificial lens is designed for implantation into the human eye to correct normal vision problems. The lens can be positioned either posteriorly from the iris or in the anterior chamber of the eye. It works in conjunction with the cornea and natural lens to provide proper vision, serving as a substitute for regular contact lenses, spectacles, and radial keratotomy. The lens can be made from rigid or semi-rigid materials, and its thin structure allows it to be rolled for insertion, minimizing corneal incision length and corneal stretching.
Another patent by Callahan details the method of implanting this deformable intraocular corrective lens. The process mirrors the functionality and positioning of the lens as described in his previous patent. This innovative approach aims to enhance the overall experience and effectiveness of vision correction procedures.
Career Highlights
Jeffrey S. Callahan is currently associated with Thinoptx, Inc., where he continues to develop groundbreaking solutions in vision correction. His work has garnered attention for its potential to revolutionize how vision problems are addressed.
Collaborations
Callahan collaborates with Wayne B. Callahan, contributing to the advancement of their shared vision in the field of ophthalmology.
Conclusion
Jeffrey S. Callahan's innovative contributions to intraocular corrective lenses highlight his commitment to improving vision correction methods. His patents reflect a deep understanding of the complexities involved in ophthalmic solutions, paving the way for future advancements in the field.